Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

Von Willebrand disease (VWD) is the most common bleeding disorder, with a reported prevalence of approximately 1 in 1000 persons caused by inherited defects in the concentration, structure, or ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

In this month's LCGC Blog, Hayley Brawley and Alexia Kreinbrink explore the challenges facing chromatographers when exploring the complex world of metal speciation. Studying metals in biology is much ...

CEO Jasbir Seehra outlined the company’s development priorities and partnership plans during a presentation at Oppenheimer’s ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI);("Scinai" or the "Company"), today announced the execution of a Second ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs through a multi-year tech and ...

Creative BioMart, a leading provider of biotechnological services specializing in protein research products and services, has officially launched its detergent micelle platform. This specialized ...